Literature DB >> 6196640

Substituted ammonium ions as allergenic determinants in drug allergy.

B A Baldo, M M Fisher.   

Abstract

Serious, and occasionally fatal, anaphylactic-like (anaphylactoid) reactions may occur when a patient is exposed to a drug for the first time. Apart from the penicillins, nothing is known of the nature of antigenic or sensitizing drug determinants and, as yet, there is no evidence for the involvement of IgE antibodies in most drug reactions. Muscle relaxants such as alcuronium have been implicated in many life-threatening anaphylactoid reactions but the mechanisms remain unclear. We have now investigated the possibility that drug-specific IgE antibodies are involved by using an alcuronium-carrier complex in a radioimmunoassay with patients' sera. Alcuronium-reactive antibodies were found in five drug-sensitive subjects and most of the antibodies cross-reacted with other muscle relaxants and with a variety of apparently structurally unrelated drugs. Structure-activity studies designed to explore the molecular basis of the antibody binding established that quaternary and tertiary ammonium ions were the complementary allergenic sites on the reactive drugs. These structures occur widely in many drugs but also in foods, cosmetics, disinfectants and industrial materials. Hence, there would seem to be ample opportunity for sensitive individuals to come into contact with and synthesize IgE antibodies to these unusual, and previously unsuspected, antigenic determinants.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6196640     DOI: 10.1038/306262a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  34 in total

Review 1.  Prevention of anaphylactic reactions to anaesthetic drugs.

Authors:  Malcolm M Fisher; Gordon S Doig
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

2.  Problems of mediator measurement for a national advisory service to U.K. anaesthetists.

Authors:  J Watkins; G Wild
Journal:  Agents Actions       Date:  1990-04

3.  [Anesthetic incompatibility--rare, but dangerous].

Authors:  G Wurpts; J M Baron
Journal:  Hautarzt       Date:  2007-01       Impact factor: 0.751

Review 4.  Nonspecific histamine-releasing properties of general anesthetic drugs.

Authors:  G Marone; C Stellato; P Mastronardi; B Mazzarella
Journal:  Clin Rev Allergy       Date:  1991 Fall-Winter

5.  In vivo and in vitro tests in anaphylactic reactions to anaesthetic agents.

Authors:  E S Assem
Journal:  Agents Actions       Date:  1991-05

Review 6.  Allergy to muscle relaxants.

Authors:  J Birnbaum; D Vervloet
Journal:  Clin Rev Allergy       Date:  1991 Fall-Winter

Review 7.  Crossreactions to muscle relaxants in the operating room.

Authors:  D A Moneret-Vautrin
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

8.  Antigenic similarity between the protein neurotoxin alpha-bungarotoxin and neuromuscular blocking drugs.

Authors:  D G Harle; B A Baldo; M M Fisher
Journal:  Agents Actions       Date:  1986-08

Review 9.  Adverse effects of depolarising neuromuscular blocking agents. Incidence, prevention and management.

Authors:  W J Book; M Abel; J B Eisenkraft
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606

10.  Inhibition of histamine-N-methyltransferase activity by neuromuscular blocking drugs.

Authors:  D G Harle; B A Baldo; M M Fisher
Journal:  Agents Actions       Date:  1985-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.